封面
市场调查报告书
商品编码
1597798

外科括约肌成形术市场:按类型、按应用分类 - 2025-2030 年全球预测

Surgical Sphincteroplasty Market by Type (Non-Surgical, Surgical (Sphincteroplasty)), Application (Ambulatory Surgery Center, Hospitals & Clinics) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年,括约肌成形术市场价值为15亿美元,预计到2024年将达到16.2亿美元,复合年增长率为8.63%,到2030年将达到26.9亿美元。

外科括约肌成形术是一种旨在修復或重组受损括约肌的手术,对于治疗因分娩、手术或老龄化引起的大便失禁等疾病至关重要。它的需要是因为当保守治疗失败时,手术可以有效地恢復肌肉功能并改善患者的生活品质。应用程式主要用于医疗保健环境,最终用户是医院、专科诊所和外科中心。市场动态是由人口老化、大便失禁病例增加以及微创手术技术的进步所推动的。然而,由于手术成本高、缺乏熟练的专业人员以及潜在的术后併发症等挑战,成长速度放缓。机会来自技术进步,例如人工智慧和机器人辅助手术的集成,提高了精确度和康復率,以及新兴市场医疗保健投资和基础设施开发的增加。抓住这些机会的建议包括投资创新手术工具的研发、与医疗保健提供者合作加强培训以及专注于可负担性以扩大市场。

主要市场统计
基准年[2023] 15亿美元
预测年份 [2024] 16.2亿美元
预测年份 [2030] 26.9亿美元
复合年增长率(%) 8.63%

根据市场洞察,北美地区因其先进的医疗保健系统和较高的认知度而占据主导地位。然而,由于医疗基础设施的扩大和患者数量的增加,亚太地区具有利润丰厚的成长潜力。大便失禁的漏报、社会耻辱以及某些人群的治疗意识有限等限制给市场带来了重大挑战。为了促进业务成长,公司应专注于患者教育计划,推广微创技术,并对括约肌成形术的长期结果进行疗效研究。创新领域包括生物工程括约肌的开发以及透过远端医疗服务加强术后护理。外科括约肌成形术市场的特点是在不断进步的推动下实现稳定成长,但需要克服文化偏见和经济障碍才能得到更广泛的接受和利用。

市场动态:快速发展的外科括约肌成形术市场的关键市场洞察

供需的动态交互作用正在改变外科括约肌成形术市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 产后肛门失禁和产科损伤的发生率和盛行率增加
    • 更多采用具成本效益的括约肌成形术
  • 市场限制因素
    • 与括约肌成形术相关的潜在併发症和风险
  • 市场机会
    • 对微创手术、较小的心臟切口和更快的术后恢復时间的需求不断增加
    • 透过合作研究和取得策略来推进括约肌成形术
  • 市场挑战
    • 缺乏熟练且训练有素的手术专业人员

波特的五力:驾驭括约肌成形术市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解对括约肌成形术市场的外部影响

外部宏观环境因素在塑造外科括约肌成形术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解外科括约肌成形术市场的竞争格局

对外科括约肌成形术市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵外科括约肌成形术市场供应商的绩效评估

FPNV 定位矩阵是评估外科括约肌成形术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议,以规划外科括约肌成形术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对外科括约肌成形术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 产后肛门失禁和产科创伤的发生率和盛行率不断增加
      • 更多采用具成本效益的括约肌成形术
    • 抑制因素
      • 与括约肌成形术相关的潜在併发症和风险
    • 机会
      • 对微创手术、较小的心臟切口和更短的术后恢復时间的需求日益增长。
      • 透过合作和收购策略开发括约肌成形术
    • 任务
      • 训练有素的外科手术专业人员数量有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章括约肌成形术市场:依类型

  • 非手术的
    • 荐椎神经刺激
    • 阴道球囊插入物
  • 手术(括约肌成形术)
    • 直接附着括约肌成形术
    • 重复括约肌成形术

第七章括约肌成形术市场:依应用分类

  • 门诊手术中心
  • 医院/诊所

第八章美洲括约肌成形术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太外科括约肌成形术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的括约肌成形术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Medtronic PLC
Product Code: MRR-3A2E844FE1EC

The Surgical Sphincteroplasty Market was valued at USD 1.50 billion in 2023, expected to reach USD 1.62 billion in 2024, and is projected to grow at a CAGR of 8.63%, to USD 2.69 billion by 2030.

Surgical sphincteroplasty, a procedure aimed at repairing or reconstructing damaged sphincter muscles, is vital for treating conditions like fecal incontinence, often resulting from childbirth, surgery, or aging. Its necessity stems from the procedure's effectiveness in restoring muscle function and improving patients' quality of life when conservative treatments fail. Applications are primarily in healthcare settings, with end-users being hospitals, specialty clinics, and surgical centers. Market dynamics are driven by an aging population, increasing fecal incontinence cases, and advancements in minimally invasive surgical techniques. However, growth is moderated by challenges such as the high cost of surgery, limited availability of skilled professionals, and potential postoperative complications. Opportunities arise from technological advancements like the integration of AI and robotic-assisted surgeries, which enhance precision and recovery rates, as well as increased healthcare investments and infrastructure developments in emerging markets. Recommendations to seize these opportunities include investing in R&D for innovative surgical tools, collaborating with healthcare providers to enhance training, and focusing on affordability to expand market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 1.50 billion
Estimated Year [2024] USD 1.62 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 8.63%

Market insights reveal that the North American region dominates due to its advanced healthcare system and high awareness levels. However, Asia-Pacific offers a lucrative growth potential due to expanding healthcare infrastructure and growing patient pool. Limitations like underreporting of fecal incontinence, societal stigma, and limited treatment awareness in certain demographics pose significant market challenges. To foster business growth, companies should focus on patient education programs, promoting minimally invasive techniques, and conducting efficacy studies on long-term outcomes of sphincteroplasty procedures. Innovation areas include developing bioengineered sphincters and enhancing postoperative care through telemedicine services. The surgical sphincteroplasty market is characterized by steady growth, driven by ongoing advancements, but necessitates overcoming cultural stigmas and affordability barriers to achieve broader acceptance and utilization.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Surgical Sphincteroplasty Market

The Surgical Sphincteroplasty Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence and prevalence of anal incontinence and obstetric injury post-childbirth
    • Increased adoption of cost-effective sphincteroplasty surgery
  • Market Restraints
    • Potential complications and risks associated with the sphincteroplasty surgery
  • Market Opportunities
    • Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
    • Development of sphincteroplasty with collaboration and acquisition strategies
  • Market Challenges
    • Limited skilled and trained professionals for surgery

Porter's Five Forces: A Strategic Tool for Navigating the Surgical Sphincteroplasty Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Surgical Sphincteroplasty Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Surgical Sphincteroplasty Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Surgical Sphincteroplasty Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Surgical Sphincteroplasty Market

A detailed market share analysis in the Surgical Sphincteroplasty Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Surgical Sphincteroplasty Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Surgical Sphincteroplasty Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Surgical Sphincteroplasty Market

A strategic analysis of the Surgical Sphincteroplasty Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Surgical Sphincteroplasty Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Baxter International Inc., and Medtronic PLC.

Market Segmentation & Coverage

This research report categorizes the Surgical Sphincteroplasty Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Non-Surgical and Surgical (Sphincteroplasty). The Non-Surgical is further studied across Sacral Nerve Stimulation and Vaginal Balloon Inserts. The Surgical (Sphincteroplasty) is further studied across Direct Apposition Sphincteroplasty and Overlapping Sphincteroplasty.
  • Based on Application, market is studied across Ambulatory Surgery Center and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence and prevalence of anal incontinence and obstetric injury post-childbirth
      • 5.1.1.2. Increased adoption of cost-effective sphincteroplasty surgery
    • 5.1.2. Restraints
      • 5.1.2.1. Potential complications and risks associated with the sphincteroplasty surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
      • 5.1.3.2. Development of sphincteroplasty with collaboration and acquisition strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled and trained professionals for surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Surgical Sphincteroplasty Market, by Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
    • 6.2.1. Sacral Nerve Stimulation
    • 6.2.2. Vaginal Balloon Inserts
  • 6.3. Surgical (Sphincteroplasty)
    • 6.3.1. Direct Apposition Sphincteroplasty
    • 6.3.2. Overlapping Sphincteroplasty

7. Surgical Sphincteroplasty Market, by Application

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Center
  • 7.3. Hospitals & Clinics

8. Americas Surgical Sphincteroplasty Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Surgical Sphincteroplasty Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Surgical Sphincteroplasty Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Baxter International Inc.
  • 3. Medtronic PLC

LIST OF FIGURES

  • FIGURE 1. SURGICAL SPHINCTEROPLASTY MARKET RESEARCH PROCESS
  • FIGURE 2. SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SURGICAL SPHINCTEROPLASTY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SURGICAL SPHINCTEROPLASTY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SURGICAL SPHINCTEROPLASTY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SURGICAL SPHINCTEROPLASTY MARKET DYNAMICS
  • TABLE 7. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY VAGINAL BALLOON INSERTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT APPOSITION SPHINCTEROPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING SPHINCTEROPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 57. CHINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 61. INDIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 130. ITALY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 146. POLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 150. QATAR SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SURGICAL (SPHINCTEROPLASTY), 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. SURGICAL SPHINCTEROPLASTY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. SURGICAL SPHINCTEROPLASTY MARKET, FPNV POSITIONING MATRIX, 2023